Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Northwest Biotherapeutics (NWBO) Operating Expenses: 2009-2024

Historic Operating Expenses for Northwest Biotherapeutics (NWBO) over the last 16 years, with Dec 2024 value amounting to $67.9 million.

  • Northwest Biotherapeutics' Operating Expenses fell 4.21% to $14.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.8 million, marking a year-over-year increase of 1.70%. This contributed to the annual value of $67.9 million for FY2024, which is 18.19% up from last year.
  • Latest data reveals that Northwest Biotherapeutics reported Operating Expenses of $67.9 million as of FY2024, which was up 18.19% from $57.4 million recorded in FY2023.
  • In the past 5 years, Northwest Biotherapeutics' Operating Expenses registered a high of $87.9 million during FY2020, and its lowest value of $53.7 million during FY2021.
  • Over the past 3 years, Northwest Biotherapeutics' median Operating Expenses value was $67.9 million (recorded in 2024), while the average stood at $64.7 million.
  • Per our database at Business Quant, Northwest Biotherapeutics' Operating Expenses skyrocketed by 189.24% in 2020 and then tumbled by 38.90% in 2021.
  • Northwest Biotherapeutics' Operating Expenses (Yearly) stood at $87.9 million in 2020, then plummeted by 38.90% to $53.7 million in 2021, then grew by 28.22% to $68.9 million in 2022, then declined by 16.59% to $57.4 million in 2023, then grew by 18.19% to $67.9 million in 2024.